Kennedy Capital Management’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-9,261
Closed -$460K 730
2018
Q1
$460K Buy
+9,261
New +$460K 0.01% 700
2017
Q4
Sell
-23,825
Closed -$1.38M 743
2017
Q3
$1.38M Sell
23,825
-13,047
-35% -$757K 0.02% 641
2017
Q2
$1.82M Buy
+36,872
New +$1.82M 0.03% 600
2016
Q2
Sell
-9,049
Closed -$405K 706
2016
Q1
$405K Hold
9,049
0.01% 702
2015
Q4
$345K Sell
9,049
-9,441
-51% -$360K 0.01% 710
2015
Q3
$589K Sell
18,490
-5,009
-21% -$160K 0.01% 683
2015
Q2
$776K Buy
23,499
+2,145
+10% +$70.8K 0.01% 686
2015
Q1
$879K Buy
21,354
+11,157
+109% +$459K 0.02% 668
2014
Q4
$415K Buy
+10,197
New +$415K 0.01% 717
2014
Q1
Sell
-18,211
Closed -$695K 740
2013
Q4
$695K Buy
18,211
+3,211
+21% +$123K 0.01% 676
2013
Q3
$358K Buy
+15,000
New +$358K 0.01% 723